|
|||||
|
|
Clinicopathologic characteristics and outcome of patients with different EGFR mutations |
|
| Authors: | Shengyu Zhou Xingsheng Hu Yan Wang Junling Li Liqiang Zhou Xuezhi Hao Yutao Liu Yuankai Shi |
| Abstract: | |
| Keywords: | EGFR‐tyrosine kinase inhibitors icotinib nonsmall cell lung cancer uncommon EGFR mutations |